NHS National Generic Pharmaceuticals - Wave 16a
NHS England is establishing a framework agreement for generic pharmaceuticals across three product categories: oral and non-parenteral products, hospital-only products, and hospital housekeeping products. This is Wave 16a, replacing prior waves, with multiple regional lots and staggered contract periods from February 2027.
- Closed8 June 2026
- Value£799m
- Per lot£266m across 3 lots
- BuyerNHS England
- CategoryHealth & medical
- RegionLondon
You'll want to look if you manufacture or distribute UK-licensed generic pharmaceutical products and can supply NHS England through regional distribution networks.
Might not suit a small firm
- the contract itself is a large one
Possible incumbent
Wave 15c awarded to 65+ suppliers including Amarox Limited, Teva UK Limited, Zentiva Pharma UK Ltd, and Wockhardt UK Limited in January 2026. Inferred from prior awards to this buyer, not confirmed.